Rice Hall James & Associates, LLC Karuna Therapeutics, Inc. Transaction History

Rice Hall James & Associates, LLC

  • $1.69 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024
BUY
$161.01 - $317.85 $1.74 Million - $3.43 Million
10,790 Added 27.4%
50,171 $15.9 Million
Q3 2023

Nov 02, 2023
BUY
$164.66 - $218.08 $3.53 Million - $4.68 Million
21,465 Added 119.81%
39,381 $6.66 Million
Q2 2023

Jul 24, 2023
SELL
$176.32 - $240.22 $49,898 - $67,982
-283 Reduced 1.56%
17,916 $3.89 Million
Q1 2023

May 11, 2023
BUY
$161.33 - $204.36 $2.94 Million - $3.72 Million
18,199 New
18,199 $3.31 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email